Biotech

All Articles

8 months after a $213M fundraise, genetics editor Volume creates cuts

.After raising $213 million in 2023-- some of the year's biggest personal biotech shots-- Volume Bio...

BioMarin creates officer team along with biotech veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable management hirings, shootings as ...

Biopharma Q2 VC struck highest level since '22, while M&ampA reduced

.Financial backing funding in to biopharma cheered $9.2 billion across 215 sell the second fourth of...

Bicara, Zenas seek IPOs to press late-phase assets towards market

.Bicara Therapies as well as Zenas Biopharma have actually supplied clean catalyst to the IPO market...

Genentech to finalize cancer immunology research team

.Genentech is going to close its own cancer immunology investigation department, and also unit head ...

Kezar goes down strong lump yet to verify its worth in stage 1 test

.Kezar Lifestyle Sciences is actually falling its own unpromising period 1 strong tumor medicine as ...

Acelyrin goes down izokibep, drops 3rd of team

.Regardless of izokibep sustaining its newfound winning touch in the center, Acelyrin is actually no...

Rivus' period 2 obesity-related cardiac arrest test reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its own fat-busting, muscl...

Ovid halts preclinical work, IV program after soticlestat fail

.Ovid Therapeutics actually exposed final month that it was actually trimming its own head count as ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has opened up a $700 million R&ampD center in the Boston Seaport, improving its own RNA a...